The medication is a glucagon-like peptide-1 receptor agonist that works by controlling blood sugar levels. The drug’s active ingredient is called dulaglutide. Other glucagon-like peptide-1 ...

For moderate to severe hypoglycemia due to diabetes, a prescription medication containing the hormone glucagon can be delivered by injection or nasal inhalation. Hypoglycemic emergencies, in which ...

Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University, Zhoushan 316021, China ...

Mounjaro is the first drug to target both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, making it a unique treatment option in the fight against ...

Prohormone convertase 1/3 (PCSK1/3) is a key enzyme in peptide processing, giving rise to peptides such as the well-known metabolic regulator glucagon-like peptide 1 (GLP-1). To identify new ...

Love Is Blind alum Chelsea Blackwell is in awe of how much weight she’s lost since taking GLP-1 medication and overhauling her diet. “I’m almost 40 pounds down since starting a GLP-1, which ...

Preparing for IBPS PO Exam 2025 requires regular practice and assessment. The IBPS PO Free Mock Test 2025 helps candidates understand the exam pattern, improve speed and identify weak areas. These ...

SBI PO Prelims Exam Analysis 2025: The State Bank of India (SBI) conducted the third and last phase Probationary Officer (PO) prelims examination on March 24, 2025. Below we have provided the ...

The addition of a candidate targeting glucagon, as well as GLP-1 and GIP, will add important optionality to our clinical pipeline, as we look to develop a broad portfolio of differentiated treatment ...

Please provide your email address to receive an email when new articles are posted on . A review of randomized clinical trials found 33 occurrences of suicide-related behaviors with GLP-1s vs 27 ...

The drug combines GLP-1 and GIP, which lower appetite and blood sugar, with glucagon, which helps prevent dangerously low blood sugar levels. “The addition of a candidate targeting glucagon ...